ORLANDO, Fla.--(BUSINESS WIRE)--Based on its long-term artificial intelligence (AI) partnership, GE HealthCare and Mass General Brigham plan to integrate medical imaging foundation models into their AI research work, with a strong focus on responsible AI practices. Both organizations have been working closely on AI solutions since announcing their 10-year commitment in 2017 to explore the use of AI across a broad range of diagnostic and treatment paradigms through sustainable AI development. “The relatio ...

GE HealthCare Technologies Inc. (GEHC) announced the publication of data that depicts its artificial intelligence (AI) models’ ability to accurately predict patient responses to immunotherapies.The study collected clinical data to accurately predict the effectiveness and toxicity of cancer immunotherapy. A pan-cancer sample's data revealed that the company’s AI models' accuracy ranged from 70% to 80%.Price PerformanceIn the past six months, GEHC shares have grown 40.9% compared with the industry’s rise of 1 ...

公司业绩 - GE HealthCare Technologies在2024年的利润和现金流有望大幅增长[1] - 公司的营收增长主要受益于有机增长，价格和销量的提升[3] - 公司的药物诊断部门表现最佳，营收增长25%[4] - 尽管营收增长，但底线业绩并不理想，净利润下降[6] - 公司发布2024年的指导意见，预计有机营收将增长约4%，调整后的每股收益也有望提升[8] 投资价值 - GE HealthCare Technologies相对于类似公司来说，股价相对便宜，具有投资价值[9] - 预计2024年公司有望实现巨大改善，股价相对其他类似公司具有吸引力[13] 业务发展 - 公司与OSF HealthCare建立战略合作联盟，收购MIM Software，积极寻求业务机会[12]

ORLANDO, Fla.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will showcase its industry-leading portfolio of artificial intelligence (AI)-enabled medical devices and digital solutions in Booth 2500 at the Health Information and Management Systems Society (HIMSS) Global Health Conference and Exhibition in Orlando, FL from March 11-15, 2024. In the U.S., clinicians spend nearly twice as much time working with electronic health records as working with patients.i This challenge is only increasing as healthcare ...

GE Healthcare (GEHC 0.53%) had an excellent start to life as a stand-alone company in 2023, and the trend has continued in 2024 with a 15% gain already this year.While it's easy to think of this recent spinoff from General Electric as a mature healthcare business, there is actually an investment case to be made for the company based on its growth opportunities. And it's those opportunities that are leading the stock to outperform.Here's why GE Healthcare is an attractive stock for investors now.GE Healthcar ...

GE HealthCare Technologies Inc. (GEHC) recently announced its advancements in its ultrasound business with the launch of its next-level LOGIQ ultrasound portfolio. This includes the new LOGIQ Totus, which highlights the company’s progress in advancing precision care.The LOGIQ E10 Series, LOGIQ Fortis and LOGIQ Totus are currently available in key countries worldwide. GE HealthCare was scheduled to demonstrate the next-generation LOGIQ portfolio at the European Congress of Radiology, held between Feb 28 and ...

Shares in leading healthcare company GE HealthCare Technologies (GEHC 1.58%) soared by 24.4% in February, according to data provided by S&P Global Market Intelligence. There's little doubt over the catalyst for the move; it comes from an excellent earnings report released in the first week of the month.GE HealthCare's growth potentialThe investment case for GE HealthCare is based on the idea that, now that it's a stand-alone company, management is free to realize its full potential. That potential lies in o ...

文章核心观点 - Zacks Premium是一个可以帮助投资者更自信地投资的研究服务 [1][2] - Zacks Style Scores是一个根据价值、成长和动量三大因素评估股票的独特指标体系 [3][4] - Zacks Rank是一个基于盈利预期变化的股票评级模型,与Style Scores配合使用可以帮助投资者选择最有潜力的股票 [9][10][12][13][14] - GE HealthCare Technologies (GEHC)是一家医疗技术公司,目前在Zacks Rank和Style Scores方面表现不错,值得关注 [15][16][17] 公司概况 - GE HealthCare Technologies是一家医疗技术、诊断和数字解决方案提供商,于2023年1月3日从通用电气公司分拆而来 [15] 财务表现 - GEHC的2024财年每股收益预期为4.30美元,较之前预期上调0.06美元 [17] - GEHC过去平均每次财报公布时的实际每股收益都高于预期9% [17] 估值情况 - GEHC的预测市盈率为21.23倍,对于价值投资者来说估值较为吸引 [16]

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced its latest innovation in ultrasound with the launch of its next-level LOGIQ ultrasound portfolio—including the new LOGIQ Totus—highlighting the company’s progress in advancing precision care. LOGIQ, is a trusted companion in general ultrasound imaging and has supported clinicians in delivering high-quality, patient-driven innovation for more than 30 years. The elevated LOGIQ portfolio innovative new features and advanced artificial intel ...

GE HealthCare Technologies Inc. (GEHC) and Biofourmis recently announced their collaboration to boost at-home health care that is easily accessible to assist patients' transitions out of hospitals.As a result of this collaboration, the companies are likely to enable more patients to return home sooner and provide them with a high-quality, at-home alternative to facility-based care, all while promoting healthy behaviors through remote patient management.Price PerformanceFor the past six months, GEHC’s shares ...